Associate Prof. of Bioengineering, University of Pisa, Head of In-Vitro Models Group and NanoBioscopy Lab at the National Council of Research Institute of Clinical Physiology (CNR-IFC). Also involved in capacity building in the field of Biomedical Engineering, in association with UNECA and FABLAB Pisa .Author of over 100 peer-reviewed publications and of several patents on microfabrication and on bioreactors, co-founder of 2 high-tech companies.
Sandra Morais Cardoso is an Assistant Professor at Faculty of Medicine and is the leader of the group of Molecular Mechanisms of Disease at the Center for Neuroscience and Cell Biology of the University of Coimbra, Portugal. Since 2006, she started her independent research and found that mitochondrial impairment causes the loss of microtubule function, culminating in microtubule depolymerization that enhances protein aggregation, via autophagic-lysosomal pathway alteration.
My work considers mtDNA disease through the prism of evolution, applying a number of techniques to develop methods to identify pathogenic mtDNA mutations. I also work on the role of mtDNA population variation in common disease, inclusive of projects centred round a single disease and method development. Others papers centre on fundamentals of mitochondrial genetics including inheritance and the selective forces that have shaped mtDNA variation in modern human populations.
Graduated in Medicine and Surgery at the University of Catania, Italy, specialist in Endocrinology and in Internal Medicine, PhD in Endocrinological and Metabolic Sciences.
Professor of Clinical Pathology, University "Magna Græcia" of Catanzaro, Italy.
Professor of Cardio-metabolic Health in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow. Lead an active multi-disciplinary research group investigating the effects of exercise and diet on the prevention and management of vascular and metabolic diseases from the molecular to the whole-body level. Major research interests include: why certain population groups appear to be particularly susceptible to the adverse effects of a ‘Westernised’ lifestyle, and how lifestyle interventions can modulate this excess risk; the interactions between physical activity, energy balance, body fatness and disease risk; and the mechanisms by which exercise regulates lipoprotein metabolism. Member of the NICE guidelines update committee for prevention of type 2 diabetes, and was member of development groups for the Scottish Intercollegiate Guidelines Network (SIGN) guidelines for the prevention and treatment of obesity and for prevention of cardiovascular disease. Past Chair of the British Association of Sport and Exercise Sciences (BASES) Division of Physical Activity for Health and Fellow of BASES. Director of the MSc programme in Sport and Exercise Science & Medicine at the University of Glasgow.
Dr. Gillespie is an evolutionary biologist with broad interests in organismal and molecular evolution. The major focus of his current research is deciphering the mechanisms by which obligate intracellular species of Rickettsiales (Alphaproteobacteria) invade, survive and replicate within eukaryotic cells.
In research funded by the National Institutes of Health, Dr. Gillespie utilizes phylogenetics, comparative genomics and bioinformatics to guide experimental research on various pathogenic species of Rickettsia and their associated arthropod vectors. His early research resulted in the reclassification of Rickettsia species and the identification of many lineage-specific pathogenicity factors. Through years of intense scrutinization of dozens of diverse rickettsial genomes, Dr. Gillespie and colleagues have described a large, dynamic mobilome for Rickettsia species, resulting in the identification of integrative conjugative elements as the vehicles for seeding Rickettsia genomes with many of the factors underlying obligate intracellular biology and pathogenesis. Via an iterative process of genome sequencing, phylogenomics, bioinformatics, and classical molecular biology and microbiology, Dr. Gillespie continues to lead and assist research projects on the characterization of rickettsial gene and protein function.
Dr. Sushil Kumar is a Research Assistant professor at the Oregon Health & Science University (OHSU), Portland Oregon. He obtained his PhD from Max Planck Institute for biochemistry, Munich Germany where he worked in supervision of prof. Axel Ullrich for studying cancer cell signaling. He did his postdoctoral work in prof. Reto Schwendener’s laboratory at University of Zurich where he developed liposomal drugs for targeted delivery of payloads to macrophages as novel cancer therapy approach. He joined OHSU in 2012 in Prof. Lisa Coussens laboratory where he has continued his research for studying cancer inflammation and developing immunotherapeutic approaches for cancer. He is employing ex vivo as well as mouse models for understanding immune cell phenotype for analyzing their role in cancer progression and developing novel therapeutics as well as biomarkers for cancer.
I received a bachelor in Animal Science from the University of California, Davis, then moved to Virginia Tech for MS and PhD degrees to study aspects of lipid metabolism in ruminants. Since joining the faculty of the University of Illinois in Fall 2005, my research program has focused on nutritional and physiological genomics during lactation and growth. We rely heavily on in vitro cell and tissue culture and live animals as models to uncover regulatory mechanisms associated with nutrient effects on tissue development and function. Transcriptomics, metabolomics, and bioinformatics are some of the tools used in an effort to apply Systems Physiology.
Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan. President of The Physiological Society of Japan. Chief Editor, Journal of Physiological Sciences; Editor, Springer Plus; Editor of Frontiers in Physiology
Assistant professor of Human Nutrition, School of Medicine and Psychology, Department of Clinical and Molecular Medicine, "La Sapienza" University, Rome, Italy. PhD in Biology and Pathology of Ageing and member of the European Association for the Study of Diabetes (EASD). Research areas: Diabetes, Endocrinology and Metabolism.
My research is focused on using cutting-edge technologies and methodologies including various "-omics" and neuroimaging approaches to better understand the genetic, environmental, behavioral and neural determinants of cancer and related co-morbidities and to improve survivorship in cancer patients, particularly in those who are overweight or obese.
Associate Professor of Medicine and Pharmacology, University of Illinois at Chicago
Heads a research group which studies:
1) embryonic stem cells, induced pluripotent stem cells, endothelial progenitor cells and adult stem cells
2) mitochondrial metabolism and mitochondrial networks in stem cells and cancer cells
3) cardiovascular repair, regeneration and angiogenesis
4) pulmonary hypertension and acute lung injury
Cardiologist and Fellow of the American Heart Association